Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 7490585, 7 pages
https://doi.org/10.1155/2018/7490585
Research Article

Association of Ki-67 Labelling Index and IL-17A with Pituitary Adenoma

1Lithuanian University of Health Sciences, Medical Academy, Department of Ophthalmology, Lithuania
2Neuroscience Institute, Lithuanian University of Health Sciences, Medical Academy, Lithuania
3Lithuanian University of Health Sciences, Medical Academy, Department of Pathology, Lithuania
4Lithuanian University of Health Sciences, Medical Academy, Department of Laboratory Medicine, Lithuania
5Lithuanian University of Health Sciences, Medical Academy, Lithuania

Correspondence should be addressed to Brigita Glebauskiene; moc.liamg@eneiksuabelgb

Received 5 February 2018; Revised 17 April 2018; Accepted 3 May 2018; Published 31 May 2018

Academic Editor: Stefan Linsler

Copyright © 2018 Brigita Glebauskiene et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Ezzat, S. L. Asa, W. T. Couldwell et al., “The prevalence of pituitary adenomas: a systematic review,” Cancer, vol. 101, no. 3, pp. 613–619, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Destrieux, M. K. Kakou, S. Velut, T. Lefrancq, and M. Jan, “Microanatomy of the hypophyseal fossa boundaries,” Journal of Neurosurgery, vol. 88, no. 4, pp. 743–752, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Colao, C. di Somma, R. Pivonello, A. Faggiano, G. Lombardi, and S. Savastano, “Medical therapy for clinically non-functioning pituitary adenomas,” Endocrine-Related Cancer, vol. 15, no. 4, pp. 905–915, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Kasputytė, G. Slatkevičienė, R. Liutkevičienė, B. Glebauskienė, G. Bernotas, and A. Tamašauskas, “Changes of Visual Functions in Patients With Pituitary Adenoma,” Medicina, vol. 49, no. 3, p. 21, 2013. View at Publisher · View at Google Scholar
  5. E. Knosp, E. Steiner, K. Kitz, and C. Matula, “Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings,” Neurosurgery, vol. 33, no. 4, pp. 610–618, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Ferrante, M. Ferraroni, T. Castrignanò et al., “Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors,” European Journal of Endocrinology, vol. 155, no. 6, pp. 823–829, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Ahmadi, C. North, H. Segall, C. Zee, and M. Weiss, “Cavernous sinus invasion by pituitary adenomas,” American Journal of Roentgenology, vol. 146, no. 2, pp. 257–262, 1986. View at Publisher · View at Google Scholar
  8. R. Fahlbusch and M. Buchfelder, “Transsphenoidal surgery of parasellar pituitary adenomas,” Acta Neurochirurgica, vol. 92, no. 1–4, pp. 93–99, 1988. View at Publisher · View at Google Scholar · View at Scopus
  9. B. W. Scheithauer, K. T. Kovacs, E. R. Laws Jr., and R. V. Randall, “Pathology of invasive pituitary tumors with special reference to functional classification,” Journal of Neurosurgery, vol. 65, no. 6, pp. 733–744, 1986. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Dai, M. Feng, X. Liu et al., “Refractory pituitary adenoma: A novel classification for pituitary tumors,” Oncotarget , vol. 7, no. 50, pp. 83657–83668, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. C. H. Moon, S. C. Hwang, B.-T. Kim, Y.-H. Ohn, and T. K. Park, “Visual prognostic value of optical coherence tomography and photopic negative response in chiasmal compression,” Investigative Ophthalmology & Visual Science, vol. 52, no. 11, pp. 8527–8533, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Thomas, K. Shenoy, M. S. Seshadri, J. Muliyil, A. Rao, and P. Paul, “Visual field defects in non-functioning pituitary adenomas,” Indian Journal of Ophthalmology, vol. 50, pp. 127–130, 2002. View at Google Scholar
  13. J. C. Trautmann and E. R. Laws Jr., “Visual status after transphenoidal surgery at the Mayo Clinic 1971-1982,” American Journal of Ophthalmology, vol. 96, pp. 200–208, 1983. View at Google Scholar
  14. A. Kaur, D. Banerji, D. Kumar, and K. Sharma, “Visual status in suprasellar pituitary tumours.,” Indian Journal of Ophthalmology, vol. 43, no. 3, pp. 131–134, 1995. View at Google Scholar · View at Scopus
  15. P. Mortini, M. Losa, R. Barzaghi, N. Boari, and M. Giovanelli, “Results of transsphenoidal surgery in a large series of patients with pituitary adenoma,” Neurosurgery, vol. 56, no. 6, pp. 1222–1233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. El-Azouzi, P. Mclaren Black, G. Candia, N. T. Zervas, and K. P. Pan s, “Transsphenoidal surgery for visual loss in patients with pituitary adenomas,” Neurological Research, vol. 12, no. 1, pp. 23–25, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Marazuela, B. Astigarraga, A. Vicente et al., “Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas,” Journal of Endocrinological Investigation, vol. 17, no. 9, pp. 703–707, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. Gondim, J. P. C. Almeida, L. A. F. Albuquerque, M. Schops, É. Gomes, and T. Ferraz, “Headache associated with pituitary tumors,” The Journal of Headache and Pain, vol. 10, no. 1, pp. 15–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Levy, H. R. Jäger, M. Powell, M. S. Matharu, K. Meeran, and P. J. Goadsby, “Pituitary Volume and Headache: Size Is Not Everything,” JAMA Neurology, vol. 61, no. 5, pp. 721–725, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Endo, Y. Ogawa, M. Watanabe, and T. Tominaga, “A Case of Pituitary Carcinoma Initially Diagnosed as an Ectopic Growth Hormone Producing Pituitary Adenoma with a High Ki-67 Labeling Index,” Journal of Neurological Surgery Part A: Central European Neurosurgery. View at Publisher · View at Google Scholar
  21. A. Hadzhiyanev, R. Ivanova, E. Nachev et al., “Evaluation of prognostic utility of MIB-1 and p53 expression in pituitary adenomas: Correlations with clinical behaviour and follow-up results,” Biotechnology & Biotechnological Equipment, vol. 28, no. 3, pp. 502–507, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. F. S. Harris and A. L. Rhoton Jr., “Anatomy of the cavernous sinus. A microsurgical study,” Journal of Neurosurgery, vol. 45, no. 2, pp. 169–180, 1976. View at Publisher · View at Google Scholar · View at Scopus
  23. C. B. Wilson, “Neurosurgical management of large and invasive pituitary tumors,” in Clinical management of pituitary disorders, G. T. Tindall, Ed., pp. 335–342, Raven, New York, NY, USA, 1979. View at Google Scholar
  24. J. Wang, B. Voellger, J. Benzel et al., “Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas,” International Journal of Cancer, vol. 139, no. 6, pp. 1327–1339, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Sun, X. Liu, Y. Yang et al., “The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor,” Journal of Molecular Neuroscience, vol. 58, no. 1, pp. 137–144, 2016. View at Publisher · View at Google Scholar
  26. I. Wierzbicka-Tutka, G. Sokołowski, A. Bałdys-Waligórska, D. Adamek, E. Radwańska, and F. Gołkowski, “PTTG and Ki-67 expression in pituitary adenomas,” Przegląd Lekarski, vol. 73, no. 2, pp. 53–58, 2016. View at Google Scholar · View at Scopus
  27. L. Mastronardi, A. Guiducci, and F. Puzzilli, “Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas.,” BMC cancer [electronic resource], vol. 1, no. 1, p. 12, 2001. View at Google Scholar · View at Scopus
  28. K. Thapar, K. Kovacs, B. W. Scheithauer et al., “Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody,” Neurosurgery, vol. 38, no. 1, pp. 99–107, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Kitz, E. Knosp, W. T. Koos, and A. Korn, “Proliferation in Pituitary Adenomas: Measurement by MAb KI 67,” in Processes of the Cranial Midline, vol. 53 of Acta Neurochirurgica Supplementum, pp. 60–64, Springer Vienna, Vienna, 1991. View at Publisher · View at Google Scholar
  30. A. Sadeghipour, L. Mahouzi, M. M. Salem et al., “Ki67 labeling correlated with invasion but not with recurrence,” Applied Immunohistochemistry & Molecular Morphology , vol. 25, no. 5, pp. 341–345, 2017. View at Publisher · View at Google Scholar · View at Scopus
  31. H. A. Zaidi, D. J. Cote, I. F. Dunn, and E. R. Laws, “Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas,” Journal of Clinical Neuroscience, vol. 34, pp. 246–251, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. J. A. Landeiro, E. O. Fonseca, A. L. Cruz Monnerat, G. F. Taboada, G. A. P. Sereno Cabral, and F. Antunes, “Nonfunctioning giant pituitary adenomas: Invasiveness and recurrence,” Surgical Neurology International, vol. 6, no. 1, article no. 179, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Yarman, N. Kurtulmus, A. Canbolat, C. Bayindir, B. Bilgic, and N. Ince, “Expression of Ki-67, p53 and vascular endothelial growth factor (VEGF) concomitantly in growth hormone-secreting pituitary adenomas; which one has a role in tumor behavior?” Neuroendocrinology Letters, vol. 31, no. 6, pp. 823–828, 2010. View at Google Scholar · View at Scopus
  34. S. Dubois, S. Guyétant, P. Menei et al., “Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery,” European Journal of Endocrinology, vol. 157, no. 2, pp. 141–147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Gandour-Edwards, S. B. Kapadia, I. P. Janecka, A. J. Martinez, and L. Barnes, “Biologic markers of invasive pituitary adenomas involving the sphenoid sinus,” Modern Pathology, vol. 8, no. 2, pp. 160–164, 1995. View at Google Scholar · View at Scopus
  36. E. Tartour, F. Fossiez, I. Joyeux et al., “Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice,” Cancer Research, vol. 59, no. 15, pp. 3698–3704, 1999. View at Google Scholar · View at Scopus
  37. L. Wang, T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng, and H. Yu, “IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway,” The Journal of Experimental Medicine, vol. 206, no. 7, pp. 1457–1464, 2009. View at Publisher · View at Google Scholar
  38. J. P. Zhang, J. Yan, J. Xu et al., “Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients,” Journal of Hepatology, vol. 50, no. 5, pp. 980–989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J.-S. Nam, M. Terabe, M.-J. Kang et al., “Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17,” Cancer Research, vol. 68, no. 10, pp. 3915–3923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Benchetrit, A. Ciree, V. Vives et al., “Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism,” Blood, vol. 99, no. 6, pp. 2114–2121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Hirahara, Y. Nio, S. Sasaki et al., “Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice,” Oncology, vol. 61, no. 1, pp. 79–89, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Qiu, D. He, X. Fan et al., “The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas,” The Pituitary Society, vol. 14, no. 3, pp. 266–275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Qiu, J. Yang, H. Wang, Y. Zhu, Y. Wang, and Q. Wu, “Expression of T-helper-associated cytokines in the serum of pituitary adenoma patients preoperatively and postperatively,” Medical Hypotheses, vol. 80, no. 6, pp. 781–786, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Al-Shraim and S. L. Asa, “The 2004 World Health Organization classification of pituitary tumors: what is new?” Acta Neuropathologica, vol. 111, no. 1, pp. 1–7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. K.-I. Paek, S.-H. Kim, S.-H. Song et al., “Clinical significance of Ki-67 labeling index in pituitary macroadenoma,” Journal of Korean Medical Science, vol. 20, no. 3, pp. 489–494, 2005. View at Publisher · View at Google Scholar · View at Scopus